Sparing Immunosuppression in Heart Transplant Recipients With Severe Sepsis

N. K. Chou, W. J. Ko, N. H. Chi, Y. S. Chen, H. Y. Yu, R. B. Hsu, C. T. Fang, S. C. Chang, F. Y. Lin, S. H. Chu, S. S. Wang

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Abstract

This study described an analysis of severe sepsis among heart transplantation recipients who were treated by sparing all immunosuppressants. Sepsis leading to multiple organ failure (MOF) in heart transplantation has a high mortality. This retrospective study of 190 patients who underwent heart transplantation from 1993 to 2004 included 12 who had severe sepsis with MOF who were treated by sparing all immunosuppressants. Half of them survived after sparing all immunosuppressants with intensive endomyocardial biopsy. Only one case needed pulse therapy for an acute rejection episode. The most common bacterial infectious episodes were caused by methicillin-resistant Staphylococcus aureus (n = 3). All sepsis episodes occurred in the first month after heart transplantation except in one case, which occurred 6 years after heart transplantation. There was a 50% survival rate of heart transplantation recipients who experienced MOF due to severe sepsis and were treated by sparing all immunosuppressants under a program of intensive endomyocardial biopsy.

Original languageEnglish
Pages (from-to)2145-2146
Number of pages2
JournalTransplantation Proceedings
Volume38
Issue number7
DOIs
Publication statusPublished - Sept 2006
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Fingerprint

Dive into the research topics of 'Sparing Immunosuppression in Heart Transplant Recipients With Severe Sepsis'. Together they form a unique fingerprint.

Cite this